Clinical Trial Update: Telbivudine Renoprotective Effect in Patients With HBV-related Liver Cirrhosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update examining whether telbivudine provides renoprotective effects in patients with hepatitis B-related liver cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B-related Liver Cirrhosis

Drugs mentioned

• Telbivudine (telbivudine)

Snippet

Sponsor: Shao-quan Zhang | Conditions: HBV-related Liver Cirrhosis | Phase 4 | Status: UNKNOWN